Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Not all Roth withdrawals are qualified. This primer outlines which withdrawals meet the qualified distribution criteria and how to maximize tax efficiency.
19,626 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
Developers shift from splashy amenities to intentional spaces that foster belonging, a move that also redefines how l...
U.S. Bancorp is emerging as a premier retirement safe haven thanks to a steady dividend, solid capital position and e...
March PMI data show slowing U.S. growth with rising costs. Bitcoin reacts nervously, facing renewed macro risk as tra...
Honeywell Aerospace becomes an independent company after the June 29, 2026 spin-off, offering a focused aerospace exp...
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...
A new State of AI report finds openai’s lead over other AI labs has largely faded as competitors close the gap, resha...
BNB rose toward the $660 mark as traders push bets higher in an aggressive spot market. Open interest on BNB futures ...
An uncalled paving crew showed up to a Lexington home, quoting a tempting price that ballooned into a $78k bill. This...
Pony AI reports unit-level profitability in Guangzhou but faces a long road to company-wide profits as it scales flee...
Nvidia stands at a crossroads: rising Chinese demand for AI GPUs could lift sales, but policy risks and fierce compet...